Original Research

microRNA-9-5p and its target nuclear factor kappa B are differentially expressed in type-2 diabetes patients

Renganathan Naveen Narayan, Ameya Kizhakke Parambath, Ashikha Shirin Usman Puthiya Purayil, Durairaj Sekar

6183-6190 |

Different concentrations of nivolumab reduce PD-1 expression but not tumour growth in an EMT6 mouse model

Nur Fatihah Ronny Sham, Harissa Husainy Hasbullah, Narimah Abdul Hamid Hasani, Nurhaslina Hasan, Suraya Othman, Nora Julianna Osman, Muhammad Khalis Abdul Karim, Syed Baharom Syed Ahmad Fuad, Mohammad Johari Ibahim

6191-6197 |

Evaluation of the success of fetoscopic laser coagulation in placental vascular anastomoses and the role of fetal vascular Doppler before laser treatment in twin-to-twin transfusion syndrome

Vajiheh Marsoosi, Nasrin Mansouri, Ali Azizi, Laleh Eslamian, Ashraf Jamal, Mahsa Naemi, Maryam Nurzade, Shideh Ariana, Masoud Sadeghi

6224-6232 |

Immunoinformatics approach to Rift Valley fever virus vaccine design in ruminants

Elijah Kolawole Oladipo, Oluseyi Rotimi Taiwo, Fashanu Omotoyosi Teniola, Adedokun Praise Temitope, Akanni Motunrayo Boluwatife, Oyewale Isaac Oluwaseyi, Bolanle Victor Oladimeji, Jonathan Iyanuoluwa Taiwo, Isaac Oluseun Adejumo

6233-6247 |

Case report

Antithrombin deficiency with portal vein and superior mesenteric vein thrombosis—a case report

Nur Ilyia Syazwani Saidin, Fatma Basyira Jamallodin, Mohd Nazri Hassan, Salfarina Iberahim, Abdul Hanan Abdullah, Muhamad Aidil Zahidin, Zefarina Zulkafli, Noor Haslina Mohd Noor

6179-6182 |

A case report of corneal abscess caused by Nocardia farcinica

Le Phuong Mai, Vo Ngoc Anh Tho, Duong Thi Thanh Van, Truong Thien Phu

6198-6202 |

First report of chronic portal vein thrombosis successfully managed with splenectomy and long-term direct oral anticoagulants

Tien Manh Huynh, Sang Thanh Nguyen, Ngoc Thanh Lam, An Le Pham, Si Van Nguyen

6203-6208 |



Copyright 2021-2023 Biomedpress. This work is licensed under a Creative Commons Attribution 4.0 License. A partner of Crossref.

Follow us: